Aspireo Pharmaceuticals Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$33.2M
Aspireo Pharmaceuticals General Information
Description
Developer of somatostatin analogs for the treatment of diseases resulting from hormone-active tumors. The company offers Somatoprim, a novel somatostatin analog used to treat patients with disorders such as diabetic retinopathy and cushings diseases.
Contact Information
Website
www.aspireopharma.comCorporate Office
- PO Box 880
- Ra'anana 43108
- Israel
Corporate Office
- PO Box 880
- Ra'anana 43108
- Israel
Aspireo Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 30-Jun-2015 | $33.2M | Completed | Generating Revenue | ||
1. Early Stage VC | 01-Dec-2010 | Completed | Startup |
Aspireo Pharmaceuticals Former Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
TVM Capital Life Science | Venture Capital | Minority |
Aspireo Pharmaceuticals FAQs
-
When was Aspireo Pharmaceuticals founded?
Aspireo Pharmaceuticals was founded in 2010.
-
Where is Aspireo Pharmaceuticals headquartered?
Aspireo Pharmaceuticals is headquartered in Ra'anana, Israel.
-
What industry is Aspireo Pharmaceuticals in?
Aspireo Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Aspireo Pharmaceuticals a private or public company?
Aspireo Pharmaceuticals is a Private company.
-
What is the current valuation of Aspireo Pharmaceuticals?
The current valuation of Aspireo Pharmaceuticals is
. -
What is Aspireo Pharmaceuticals’s current revenue?
The current revenue for Aspireo Pharmaceuticals is
. -
Who are Aspireo Pharmaceuticals’s investors?
TVM Capital Life Science has invested in Aspireo Pharmaceuticals.
-
When was Aspireo Pharmaceuticals acquired?
Aspireo Pharmaceuticals was acquired on 30-Jun-2015.
-
Who acquired Aspireo Pharmaceuticals?
Aspireo Pharmaceuticals was acquired by Strongbridge Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »